MENU
AMLX
AS OF
Dec 24 closing price
Price
$12.49
Change
+$0.18 (+1.46%)
Capitalization
1.37B
97 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AMLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amylyx Pharmaceuticals (AMLX) Ownership - Who owns Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.37B
P/E Ratio
2.69
Total Cash
343.99M
Projected Growth
N/A
Total Debt
5.94M
Revenue
-665K
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
3.13
Total Debt/Equity
N/A
Revenue/Share
-0.01 USD as % of share price

Fundamentals

AMLX
Capitalization
1.37B
P/E Ratio
2.69
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash
344M
Total Cash/Share
3.13
Total Debt
5.94M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
-0.01%
Revenue
-665K
ROE
N/A
Book Value
332M
P/B Ratio
4.13
Cash Flow
N/A
Earnings
-1.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
13.70
Current Revenue Per Employee
1083.33
Dividends Per Share - Security
N/A
EBITDA
-156.76M
Float
N/A
Float - Current
N/A
Gross Income Margin
-94.47
Revenue To Assets
-48.67
Shares Held By Institutions
1.94B
Shares Outstanding - Current
110M
Total Liabilities
30.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
230.423
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AMLX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AMLX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for AMLX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com